237 related articles for article (PubMed ID: 10773819)
1. Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance.
Fernández Y; España L; Mañas S; Fabra A; Sierra A
Cell Death Differ; 2000 Apr; 7(4):350-9. PubMed ID: 10773819
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of Bcl-xL in human breast cancer cells enhances organ-selective lymph node metastasis.
España L; Fernández Y; Rubio N; Torregrosa A; Blanco J; Sierra A
Breast Cancer Res Treat; 2004 Sep; 87(1):33-44. PubMed ID: 15377849
[TBL] [Abstract][Full Text] [Related]
3. Scatter factor protects epithelial and carcinoma cells against apoptosis induced by DNA-damaging agents.
Fan S; Wang JA; Yuan RQ; Rockwell S; Andres J; Zlatapolskiy A; Goldberg ID; Rosen EM
Oncogene; 1998 Jul; 17(2):131-41. PubMed ID: 9674697
[TBL] [Abstract][Full Text] [Related]
4. Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Dole MG; Jasty R; Cooper MJ; Thompson CB; Nuñez G; Castle VP
Cancer Res; 1995 Jun; 55(12):2576-82. PubMed ID: 7780971
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2-mediated cell survival promotes metastasis of EpH4 betaMEKDD mammary epithelial cells.
Pinkas J; Martin SS; Leder P
Mol Cancer Res; 2004 Oct; 2(10):551-6. PubMed ID: 15498929
[TBL] [Abstract][Full Text] [Related]
6. Astrocyte-derived cytokines contribute to the metastatic brain specificity of breast cancer cells.
Sierra A; Price JE; García-Ramirez M; Méndez O; López L; Fabra A
Lab Invest; 1997 Oct; 77(4):357-68. PubMed ID: 9354770
[TBL] [Abstract][Full Text] [Related]
7. Bcl-XL protects cancer cells from p53-mediated apoptosis.
Schott AF; Apel IJ; Nuñez G; Clarke MF
Oncogene; 1995 Oct; 11(7):1389-94. PubMed ID: 7478561
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.
Bargou RC; Wagener C; Bommert K; Mapara MY; Daniel PT; Arnold W; Dietel M; Guski H; Feller A; Royer HD; Dörken B
J Clin Invest; 1996 Jun; 97(11):2651-9. PubMed ID: 8647960
[TBL] [Abstract][Full Text] [Related]
9. Involvement of bcl-2 and p21waf1 proteins in response of human breast cancer cell clones to Tomudex.
Orlandi L; Bearzatto A; Abolafio G; De Marco C; Daidone MG; Zaffaroni N
Br J Cancer; 1999 Sep; 81(2):252-60. PubMed ID: 10496350
[TBL] [Abstract][Full Text] [Related]
10. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
Jackson JG; Zhang X; Yoneda T; Yee D
Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
[TBL] [Abstract][Full Text] [Related]
11. Antisense RNA down-regulation of bcl-xL Expression in prostate cancer cells leads to diminished rates of cellular proliferation and resistance to cytotoxic chemotherapeutic agents.
Vilenchik M; Raffo AJ; Benimetskaya L; Shames D; Stein CA
Cancer Res; 2002 Apr; 62(7):2175-83. PubMed ID: 11929841
[TBL] [Abstract][Full Text] [Related]
12. Bcl-XL induction during terminal differentiation of friend erythroleukaemia cells correlates with delay of apoptosis and loss of proliferative capacity but not with haemoglobinization.
Hafid-Medheb K; Poindessous-Jazat V; Augery-Bourget Y; Hanania N; Robert-Lézénès J
Cell Death Differ; 1999 Feb; 6(2):166-74. PubMed ID: 10200563
[TBL] [Abstract][Full Text] [Related]
13. Modulation of apoptosis by endogenous Bcl-xL expression in MKN-45 human gastric cancer cells.
Kondo S; Shinomura Y; Kanayama S; Higashimoto Y; Kiyohara T; Zushi S; Kitamura S; Ueyama H; Matsuzawa Y
Oncogene; 1998 Nov; 17(20):2585-91. PubMed ID: 9840921
[TBL] [Abstract][Full Text] [Related]
14. Interconnections between E2-dependent regulation of cell cycle progression and apoptosis in MCF-7 tumors growing on nude mice.
Truchet I; Jozan S; Guerrin M; Mazzolini L; Vidal S; Valette A
Exp Cell Res; 2000 Feb; 254(2):241-8. PubMed ID: 10640422
[TBL] [Abstract][Full Text] [Related]
15. [The effects of antisense oligonucleotides bcl-2/bcl-xl and bcl-2 on proliferation and apoptosis of breast cancer cells].
Ma C; Xie JW; Kuang AR; Huang R; Tang GS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):780-3. PubMed ID: 19950582
[TBL] [Abstract][Full Text] [Related]
16. Suppression of protein kinase Calpha triggers apoptosis through down-regulation of Bcl-xL in a rat hepatic epithelial cell line.
Hsieh YC; Jao HC; Yang RC; Hsu HK; Hsu C
Shock; 2003 Jun; 19(6):582-7. PubMed ID: 12785016
[TBL] [Abstract][Full Text] [Related]
17. Effects of Bcl-2 and Bcl-XL protein levels on chemoresistance of hepatoblastoma HepG2 cell line.
Luo D; Cheng SC; Xie H; Xie Y
Biochem Cell Biol; 2000; 78(2):119-26. PubMed ID: 10874473
[TBL] [Abstract][Full Text] [Related]
18. Expression of Siva-1 protein or its putative amphipathic helical region enhances cisplatin-induced apoptosis in breast cancer cells: effect of elevated levels of BCL-2.
Chu F; Barkinge J; Hawkins S; Gudi R; Salgia R; Kanteti PV
Cancer Res; 2005 Jun; 65(12):5301-9. PubMed ID: 15958577
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Walczak H; Bouchon A; Stahl H; Krammer PH
Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
